Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zineb Maaradji

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancers|March 29, 2023
Immunotherapy for Solid TumorsHortense de Saint Basile, Zineb Maaradji, Elizabeth Fabre
Exploration of Targeted Anti-Tumor Therapy|January 7, 2025
Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancerHortense De Saint Basile, Reza Elaidi, Zineb Maaradji, et al.
JCO Precision Oncology|August 1, 2024
Disease Course and Treatment Outcomes in Patients With De Novo Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 20 Insertion: Two Case ReportsLodovica Zullo, Elora Castanet, Zineb Maaradji, et al.
Cancers|December 9, 2023
Longitudinal Study of Advanced Non-Small Cell Lung Cancer with Initial Durable Clinical Benefit to Immunotherapy: Strategies for Anti-PD-1/PD-L1 Continuation beyond ProgressionIvan Pourmir, Reza Elaidi, Zineb Maaradji, et al.
Pathology|June 4, 2024
Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practiceSimon Garinet, Audrey Lupo, Thomas Denize, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancers|March 29, 2023
Immunotherapy for Solid TumorsHortense de Saint Basile, Zineb Maaradji, Elizabeth Fabre
Exploration of Targeted Anti-Tumor Therapy|January 7, 2025
Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancerHortense De Saint Basile, Reza Elaidi, Zineb Maaradji, et al.
JCO Precision Oncology|August 1, 2024
Disease Course and Treatment Outcomes in Patients With De Novo Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 20 Insertion: Two Case ReportsLodovica Zullo, Elora Castanet, Zineb Maaradji, et al.
Cancers|December 9, 2023
Longitudinal Study of Advanced Non-Small Cell Lung Cancer with Initial Durable Clinical Benefit to Immunotherapy: Strategies for Anti-PD-1/PD-L1 Continuation beyond ProgressionIvan Pourmir, Reza Elaidi, Zineb Maaradji, et al.
Pathology|June 4, 2024
Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practiceSimon Garinet, Audrey Lupo, Thomas Denize, et al.
Pageof 1